BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies

Reuters

Jan 14

** Jefferies views Australia's Monash IVF MVF.AX as an attractive asset, despite consortium withdrawing A$311.7 million ($208.25 million) takeover offer in 2025

** "Would not be surprised to see further potential corporate actions over time" — Jefferies

** Brokerage keeps its forecasts unchanged

** Rates stock "buy", hikes PT to A$0.95 from A$0.80 per share

** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector

** Three of six analysts rate the stock "buy" or higher, three "hold"; their median PT is A$0.84 — LSEG data

** Stock lost over 40% in 2025

($1 = 1.4968 Australian dollars)

(Reporting by Rajasik Mukherjee in Bengaluru)

((Rajasik.Mukherjee@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2603630797"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603630797\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603630797?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 05:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603630797","market":"nz","top_or_hot":-1,"title":"BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies</title></head><body><p>** Jefferies views Australia's Monash IVF <span>MVF.AX</span> as an attractive asset, despite consortium <span>withdrawing</span> A$311.7 million ($208.25 million) takeover offer in 2025</p><p>** \"Would not be surprised to see further potential corporate actions over time\" — Jefferies</p><p>** Brokerage keeps its forecasts unchanged</p><p>** Rates stock \"buy\", hikes PT to A$0.95 from A$0.80 per share</p><p>** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector</p><p>** Three of six analysts rate the stock \"buy\" or higher, three \"hold\"; their median PT is A$0.84 — LSEG <span>data</span></p><p>** Stock lost over 40% in 2025</p><p>($1 = 1.4968 Australian dollars)</p><p>(Reporting by Rajasik Mukherjee in Bengaluru)</p><p>((Rajasik.Mukherjee@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Monash IVF is an attractive asset, says Jefferies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-14 05:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies</title></head><body><p>** Jefferies views Australia's Monash IVF <span>MVF.AX</span> as an attractive asset, despite consortium <span>withdrawing</span> A$311.7 million ($208.25 million) takeover offer in 2025</p><p>** \"Would not be surprised to see further potential corporate actions over time\" — Jefferies</p><p>** Brokerage keeps its forecasts unchanged</p><p>** Rates stock \"buy\", hikes PT to A$0.95 from A$0.80 per share</p><p>** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector</p><p>** Three of six analysts rate the stock \"buy\" or higher, three \"hold\"; their median PT is A$0.84 — LSEG <span>data</span></p><p>** Stock lost over 40% in 2025</p><p>($1 = 1.4968 Australian dollars)</p><p>(Reporting by Rajasik Mukherjee in Bengaluru)</p><p>((Rajasik.Mukherjee@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MVF.AU","symbol_name":"MONASH IVF GROUP LTD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nL4N3YE1ZE:1","article_id":"2603630797","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603630797","pubTimestamp":1768338295,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies** Jefferies views Australia's Monash IVF MVF.AX as an attractive asset, despite consortium withdrawing A$311.7 million  takeover offer in 2025** \"Would not be surprised to see further potential corporate actions over time\" — Jefferies** Brokerage keeps its forecasts unchanged** Rates stock \"buy\", hikes PT to A$0.95 from A$0.80 per share** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector** Three of six analysts rate the stock \"buy\" or higher, three \"hold\"; their median PT is A$0.84 — LSEG data** Stock lost over 40% in 2025","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MVF.AU":"MONASH IVF GROUP LTD","BK7113":"保健护理机构","BK7508":"医药生物股"},"translate_title":"杰富瑞(Jefferies)表示，澳大利亚莫纳什IVF是一项有吸引力的资产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MVF.AU":0.9},"content_text":"BUZZ-Australia's Monash IVF is an attractive asset, says Jefferies** Jefferies views Australia's Monash IVF MVF.AX as an attractive asset, despite consortium withdrawing A$311.7 million ($208.25 million) takeover offer in 2025** \"Would not be surprised to see further potential corporate actions over time\" — Jefferies** Brokerage keeps its forecasts unchanged** Rates stock \"buy\", hikes PT to A$0.95 from A$0.80 per share** Jefferies says supportive demographics and IVF being a high cash flow business have lured in private equity interest in the IVF sector** Three of six analysts rate the stock \"buy\" or higher, three \"hold\"; their median PT is A$0.84 — LSEG data** Stock lost over 40% in 2025($1 = 1.4968 Australian dollars)(Reporting by Rajasik Mukherjee in Bengaluru)((Rajasik.Mukherjee@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}